Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
The Chloride Ion (DB14547): A Comprehensive Monograph on its Physicochemical Properties, Physiological Functions, and Clinical Significance
Section 1: Introduction: Beyond a Simple Molecule
The chloride ion (Cl−), cataloged in the DrugBank database as DB14547, represents a unique entry in the pharmacological compendium.[1] Unlike conventional therapeutic agents, which are typically xenobiotic compounds designed to elicit a specific biological response, chloride is the most abundant extracellular anion in the human body, a fundamental electrolyte indispensable for life.[3] Its classification as an investigational "Small Molecule" within such a database stems not from a primary pharmacological activity in the traditional sense, but from its ubiquitous presence in a vast array of therapeutic formulations, where it serves as a counter-ion, an essential component of intravenous hydration solutions, or as part of an active pharmaceutical ingredient.[1]
The presence of chloride ion in listings for clinical trials for conditions ranging from urinary tract infections to various cancers can be misleading.[7] A detailed examination reveals that in these contexts, chloride is not the substance under investigation. Instead, it is a constituent of the therapeutic regimen—for example, as the counter-ion in chlorhexidine, a ligand in the cisplatin molecule, or the principal anion in the 0.9% sodium chloride (saline) solution used as a vehicle for drug delivery or for patient hydration.[7] This distinction is critical: chloride's
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/08/03 | Not Applicable | Not yet recruiting | |||
2025/07/22 | Not Applicable | Not yet recruiting | Hope Biosciences | ||
2025/07/09 | Not Applicable | Recruiting | |||
2025/07/04 | Not Applicable | Not yet recruiting | |||
2025/04/01 | Phase 3 | Completed | |||
2025/02/12 | Phase 4 | Not yet recruiting | Liquan Liang | ||
2025/01/06 | Phase 1 | Recruiting | Chengdu Brilliant Pharmaceutical Co., Ltd. | ||
2024/11/05 | Phase 1 | ENROLLING_BY_INVITATION | Shanghai Reinovax Biologics Co.,LTD | ||
2024/10/26 | Phase 1 | Completed | |||
2024/09/26 | Phase 1 | Recruiting | Qianfoshan Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
TURK ILAC VE SERUM SANAYI ANONIM SIRKETI | 85160-200 | INTRAVENOUS | 0.9 g in 100 mL | 3/28/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.